CliffBio
small molecule

NITHIODOTE

SODIUM NITRITE; SODIUM THIOSULFATE

Loss of exclusivityDecember 2031latest FDA-listed patent expiry
CompanyHOPE PHARMACEUTICALS

Drug detail

Brand nameNITHIODOTE
Active ingredientSODIUM NITRITE; SODIUM THIOSULFATE
Strength300MG/10ML(30MG/ML),N/A;N/A,12.5GM/50ML(250MG/ML)
Dosage formSOLUTION, SOLUTION
RouteINTRAVENOUS, INTRAVENOUS
ModalitySmall molecule
FDA approvalJanuary 2011
Marketing statusRX

Listed patents

PatentExpiresType
8568793December 2031substance, product
8496973March 2031substance, product
9345724July 2030substance, product
10479686July 2030product
9585912July 2030substance, product
9687506February 2030product
12304813February 2030product
11753301February 2030substance, product

More from HOPE PHARMACEUTICALS

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

NITHIODOTE patent cliff — loss of exclusivity December 2031 | CliffBio